Pfizer launches clinical trial testing its COVID-19 pill in children aged 6 and older
(NEW YORK) -- Pfizer announced Wednesday it is launching a clinical trial to study the effectiveness of its COVID-19 antiviral pill in young children.The treatment, Paxlovid, was authorized in December 2020 by the U.S. Food and Drug Administration for emergency use in patients aged... Read More.